Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B S Mitchell

Showing results (131-140 of 140) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 140 results.
Proceedings of the National Academy of Sciences of the United States of America|November 26, 1999
Association of terminal deoxynucleotidyl transferase with KuK N Mahajan, L Gangi-Peterson, D H Sorscher, et al.
Current Atherosclerosis Reports|October 17, 2001
Innovative approaches to comprehensive cardiovascular disease risk reduction in clinical and community-based settingsN F Gordon, R D Salmon, B S Mitchell, et al.
The New England Journal of Medicine|July 30, 1987
Effect of spectinomycin use on the prevalence of spectinomycin-resistant and of penicillinase-producing Neisseria gonorrhoeaeJ W Boslego, E C Tramont, E T Takafuji, et al.
Leukemia|September 1, 1989
Association of a mature B cell leukemia with a 4p+ chromosomal abnormality: derivation and characterization of a cell lineT E Gribbin, C K Stein, J S Harrison, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 14, 2002
Alemtuzumab in previously treated chronic lymphocytic leukemia patients who also had received fludarabineK R Rai, C E Freter, R J Mercier, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 17, 1998
Compound GW506U78 in refractory hematologic malignancies: relationship between cellular pharmacokinetics and clinical responseV Gandhi, W Plunkett, C O Rodriguez, et al.
The American Journal of Tropical Medicine and Hygiene|September 1, 1993
Prevalence of hepatitis C viral antibody in transfused and nontransfused Egyptian childrenA S Khalifa, B S Mitchell, D M Watts, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 1, 1997
Systemic reactions in U.S. Marine Corps personnel who received Japanese encephalitis vaccineS W Berg, B S Mitchell, R K Hanson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 24, 2005
Phase I study of 506U78 administered on a consecutive 5-day schedule in children and adults with refractory hematologic malignanciesJ Kurtzberg, T J Ernst, M J Keating, et al.
Leukemia|October 29, 2011
Safety, efficacy and biological predictors of response to sequential azacitidine and lenalidomide for elderly patients with acute myeloid leukemiaD A Pollyea, H E Kohrt, L Gallegos, et al.
Pageof 14

Showing results (131-140 of 140) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 140 results.
Proceedings of the National Academy of Sciences of the United States of America|November 26, 1999
Association of terminal deoxynucleotidyl transferase with KuK N Mahajan, L Gangi-Peterson, D H Sorscher, et al.
Current Atherosclerosis Reports|October 17, 2001
Innovative approaches to comprehensive cardiovascular disease risk reduction in clinical and community-based settingsN F Gordon, R D Salmon, B S Mitchell, et al.
The New England Journal of Medicine|July 30, 1987
Effect of spectinomycin use on the prevalence of spectinomycin-resistant and of penicillinase-producing Neisseria gonorrhoeaeJ W Boslego, E C Tramont, E T Takafuji, et al.
Leukemia|September 1, 1989
Association of a mature B cell leukemia with a 4p+ chromosomal abnormality: derivation and characterization of a cell lineT E Gribbin, C K Stein, J S Harrison, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 14, 2002
Alemtuzumab in previously treated chronic lymphocytic leukemia patients who also had received fludarabineK R Rai, C E Freter, R J Mercier, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 17, 1998
Compound GW506U78 in refractory hematologic malignancies: relationship between cellular pharmacokinetics and clinical responseV Gandhi, W Plunkett, C O Rodriguez, et al.
The American Journal of Tropical Medicine and Hygiene|September 1, 1993
Prevalence of hepatitis C viral antibody in transfused and nontransfused Egyptian childrenA S Khalifa, B S Mitchell, D M Watts, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 1, 1997
Systemic reactions in U.S. Marine Corps personnel who received Japanese encephalitis vaccineS W Berg, B S Mitchell, R K Hanson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 24, 2005
Phase I study of 506U78 administered on a consecutive 5-day schedule in children and adults with refractory hematologic malignanciesJ Kurtzberg, T J Ernst, M J Keating, et al.
Leukemia|October 29, 2011
Safety, efficacy and biological predictors of response to sequential azacitidine and lenalidomide for elderly patients with acute myeloid leukemiaD A Pollyea, H E Kohrt, L Gallegos, et al.
Pageof 14